ArticleProceedings of the National Academy of Sciences of the United States of America2006

Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.

Mohammad Azam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.